MASTERCLASS SERIES

Masterclass #12: Carotid T thrombectomies: A competitive field between stentriever and aspiration?

Replay of Masterclass #12

March 4, 2021 - 14:00-15:10

Vincent COSTALAT, Urs FISCHER, Vitor MENDES PEREIRA, Jacques MORET, Laurent SPELLE

After large-vessel ischemic strokes, it’s been seen that 90-day results of endovascular thrombectomies were worse after treating carotid-T occlusions than M1 occlusions. What makes carotid-T occlusions so challenging?

Join Professors Jacques Moret and Laurent Spelle along with their expert panel as they explore the key elements involved, including…

The challenge of collateral circulation in carotid-T occlusions:

  • These occlusions might have little or no anterior circulation – if the collateral flow is compromised, what is the outcome?
  • Speed and technique are critical in removing clots in these situations, but should we use a medical approach first?  What evidence do we have to make our decision?

High clot volume – the clot burden of carotid-T occlusions: 

  • What is the importance of clot mass?
  • Does clot size equally impact the efficacy of mechanical thrombectomy and thrombolytics?
  • Which type of occlusions would lytics be most effective in? Is thrombolysis more effective if the occlusion is distal?
  • Can clot size affect the number of passes necessary for MT?

Mechanical thrombectomy techniques used in managing carotid-T occlusions – from stentriever or aspiration alone, or both in the “full” or “BADDASS” technique.

  • Learn why the treatment of carotid-T occlusions, with their greater clot load and larger vessel diameter, are perfectly suited for any of these MT strategies.
  • Discover ongoing trials such as SWIFT DIRECT and what current studies and trials say about the preferred MT strategy to employ.

Specially chosen cases further illustrate:

  • The dangers involved in embolization.
  • Which type of anesthesia or conscious sedation should be preferred in treating carotid-T occlusions and whether patient age could play a role in which one to use.
  • Issues involved in thrombolysis – could it useful before or after MT? Does bridging thrombolysis necessarily prevent using lytics after an intervention?
  • What impact has the COVID pandemic had on the management of these patients?

PLEASE LOG IN OR CREATE A FREE LINNC ONLINE ACCOUNT

Join now the LINNC online community!

Not registered yet? Create your 100% free LINNC online account in less than 1 minute and enjoy a full range of educational content: LIVE & recorded cases from LINNC Courses and Seminars, expert interviews, cases shared by worldwide experts, latest news from Interventional neuroradiology field and much more!

LINNC online is also an interactive platform on which you can join your peers, share comments, live chat during LINNC Masterclass or answer polls.

You already have an account:

Create your account:

Your free LINNC account will offer you access to:
  • LINNC Masterclass Replays & Lives
  • Cases commented by experts on various topics
  • A full library of LIVE cases from LINNC Course
  • Recorded Cases commented during the LINNC Course and Seminars
  • And much more…